Biolase gains FDA nod for diode laser

Biolase has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval for its Epic 10 diode soft-tissue laser.

The laser allows for cleaner cutting, better hemostasis, improved patient comfort, and greater versatility, according to the company. It also features an applications-based user interface with a touchscreen preprogrammed with 15 commonly performed soft-tissue procedures, including pain therapy in the oral-maxillofacial region.

The Epic 10 also incorporates ComfortPulse, Biolase's proprietary technology that allows dentists to precisely control the level of laser energy that penetrates the target tissue, the company noted.

Page 1 of 272
Next Page